DiaMedica Therapeutics Inc.
For the period ended May 20, 2026. Filed Apr 1, 2026.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
May 20, 2026 · Filed Apr 1, 2026
DMAC$9.36+3.5%Stored close · as of Nov 6, 2026
Contents
PROXY STATEMENT SUMMARY
This summary provides an overview of the information included in this proxy statement. We recommend that you review the entire proxy statement and our Annual Report to Shareholders before voting.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.